GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News)

Publication
0 followers

Genetic Engineering & Biotechnology News (GEN) offers global news and information on biotech and genetic engineering, including analysis, industry data, and technology updates.

Advances in Extracellular Vesicle Separation and Isolation
NewsJan 7, 2026

Advances in Extracellular Vesicle Separation and Isolation

Finnish researchers reviewed the latest size‑, charge‑, and affinity‑based methods for extracellular vesicle (EV) isolation as exosome therapeutics move toward clinical use. They highlighted emerging size‑based techniques such as deterministic lateral displacement (DLD) with thermally‑oxidized tapered structures and viscoelastic microfluidic...

By GEN (Genetic Engineering & Biotechnology News)
Fungus with Hidden Talent Leads to Rethink on Making Classic Cancer Drug
NewsJan 7, 2026

Fungus with Hidden Talent Leads to Rethink on Making Classic Cancer Drug

Researchers have identified an endophytic fungus, *Colletotrichum siamense*, living inside the Madagascar periwinkle that can synthesize the chemotherapy drug vinblastine. The fungus produced the compound at a modest 138 µg per liter, matching the plant‑derived molecular signature. Laboratory tests confirmed that...

By GEN (Genetic Engineering & Biotechnology News)
Automated Lab of the Future May Herald Lower-Cost Therapies
NewsJan 7, 2026

Automated Lab of the Future May Herald Lower-Cost Therapies

German researchers at TU Berlin’s KIWI‑biolab have built a self‑driving laboratory that uses robotics, AI and bioinformatics to automate the development of new biomolecules. The system runs E. coli cultures in 10‑100 mL bioreactors, validates processes up to 100 L, and relies on...

By GEN (Genetic Engineering & Biotechnology News)
CCGT Sector Needs Purpose-Built Quality Management Systems
NewsJan 7, 2026

CCGT Sector Needs Purpose-Built Quality Management Systems

Researchers argue that traditional quality management systems, built for large‑scale protein drugs, are ill‑suited for cell and gene therapy (CGT) manufacturing. Manual, paper‑based processes have evolved into fragile eQMS platforms that struggle with the lean, modular nature of CGT production....

By GEN (Genetic Engineering & Biotechnology News)